Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Ginsenosides, the primary active compounds in ginseng, have been investigated for their potential lipid-lowering effects, including the reduction of high triglyceride levels. Several preclinical studies (in vitro and animal models) suggest that certain ginsenosides can modulate lipid metabolism, reduce hepatic lipid accumulation, and improve overall lipid profiles. For example, ginsenoside Rb1 and Rg1 have been shown to enhance the activity of lipoprotein lipase and promote fatty acid oxidation, leading to decreased plasma triglyceride concentrations in animal models. Some small human clinical trials and meta-analyses have suggested that ginseng supplementation may modestly lower triglyceride levels, but results are inconsistent and often limited by small sample sizes, short study durations, and heterogeneity in ginseng preparations and dosages.

Overall, while there is plausible scientific rationale and some early evidence supporting the use of ginsenosides for high triglycerides, robust clinical evidence in humans is lacking. The majority of available data are preclinical or derived from studies with methodological limitations. As such, ginsenosides cannot yet be considered a validated treatment for high triglycerides, but there is enough preliminary evidence to merit further research. Current guidelines do not recommend their use as a primary intervention for hypertriglyceridemia.

More about Ginsenosides (unspecified)
More about Triglycerides (high)

Other ingredients used for Triglycerides (high)

Other health conditions supported by Ginsenosides (unspecified)

Products containing Ginsenosides (unspecified)